Trial Profile
A novel protocol for anti coagulation therapy after coronary endarterectomy in coronary artery bypass graft patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2016
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary) ; Warfarin (Primary)
- Indications Coronary artery disease
- Focus Pharmacodynamics; Therapeutic Use
- 14 Dec 2016 New trial record